Japanese maker of sake, shochu and mirin cooking wine, and majority owner of biotech firm Takara Bio.
Japanese maker of sake, shochu and mirin cooking wine, and majority owner of biotech firm Takara Bio.
Two unlike businesses under one holding: shochu, sake and mirin sold through wholesalers and shops in Japan at mature volumes, and Takara Bio, a separately listed subsidiary that sells research reagents and contract gene-therapy manufacturing to labs and drug developers. Beverages bring the steadier cash; the bio side swings with research spending.
In one line: A sake brewer with a biotech subsidiary attached.
Moat: narrow (brand, IP / patents). Established sake/mirin brand plus Takara Bio's PCR reagent and gene-therapy IP portfolio.
Headquarters: Kyoto, Japan · Founded: 1842 · Employees: 5,720
Size Takara (2531.T) is a Japan Consumer Staples company (Beverages: Alcoholic) with a market value of $3.33B, the 339th largest of 1,370 Japan companies the cockpit tracks. Shares closed at ¥2,748 on 18 Nov 2026.
Performance Over six months the shares gained 50.7%, against +7.6% for the median peer and -1.4% for the Japan market (cap-weighted) — highest of 21 in its peer set.
Growth Revenue grew 12.3% over the last twelve months (peer median -4.5%); the operating margin is 5.3% (peer median 14.6%).
Valuation It trades at 30.3× forward earnings against a peer median of 21.3× (6th most expensive of 21).
Capital Return on invested capital runs 1.4 points below its cost of capital (6.1% WACC).
Next results Next results expected around 18 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ¥419B | ¥394B | ¥363B | ¥339B | ¥351B |
| Revenue growth | — | +9% | +7% | -3% | — |
| Gross profit | ¥136B | ¥122B | ¥115B | ¥110B | ¥117B |
| EBITDA | ¥38.2B | ¥32.4B | ¥32.7B | ¥33.4B | ¥48.1B |
| Net income | ¥17.7B | ¥11.7B | ¥16.2B | ¥16.2B | ¥21.2B |
| Free cash flow | n/a | -¥4.85B | -¥3.99B | ¥9.96B | ¥34.9B |
| Capital expenditure | n/a | ¥22.2B | ¥20.1B | ¥19.2B | ¥10.6B |
| Total debt | ¥111B | ¥98.3B | ¥93.0B | ¥49.0B | ¥45.5B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Takara 2531.T | $3.33B | +51% | +12% | 5% | 30.3× | n/a |
| Asahi Group Hldgs 2502.T | $17.4B | +18% | +4% | 9% | 14.0× | 1.2% |
| Kirin 2503.T | $15.9B | +22% | +6% | 11% | 14.5× | -3.2% |
| Thermo Fisher Scientific TMO | $257B | +53% | +8% | 19% | 25.7× | 21.3% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 2531.T | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -7.2% | +3.0% | 3rd lowest of 21 |
| 6-month return | +50.7% | +7.6% | highest of 21 |
| Distance from 52-week high | -22.5% | -20.8% | 10th lowest of 21 |
| Revenue growth (TTM) | +12.3% | -4.5% | 3rd highest of 21 |
| Operating margin | 5.3% | 14.6% | 4th lowest of 21 |
| Forward P/E | 30.3× | 21.3× | 6th most expensive of 21 |
| ROIC minus cost of capital | -1.4 pp | +0.4 pp | 8th lowest of 21 |
| EV / EBITDA | 15.4× | 16.4× | 6th cheapest of 11 |
| Net debt / EBITDA | 1.2× | 1.3× | 6th least indebted of 11 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Takara 2531.T | Japan | $3.33B | +51% | +12% | 5% | 30.3× | n/a | n/a |
| ZJLD 6979.HK | Hong Kong | $3.35B | +4% | -29% | 13% | 27.1× | n/a | n/a |
| Treasury Wine Estates TWE.AX | Australia | $3.40B | +38% | -12% | 17% | 18.2× | 9.2% | -0.4% |
| Royal Unibrew A/S RBREW.CO | Denmark | $3.45B | +17% | +2% | 15% | 14.2× | -7.6% | +16.5% |
| United Breweries UBL.NS | India | $3.46B | -9% | +7% | 6% | 66.3× | n/a | n/a |
| Remy Cointreau RCO.PA | France | $2.94B | +28% | -5% | 16% | 28.5× | 16.9% | -1.5% |
| Chongqing Brewery 600132.SS | China | $2.87B | -24% | -4% | 20% | 17.3× | -8.9% | +6.2% |
| Guangzhou Zhujiang Brewery 002461.SZ | China | $2.79B | -13% | +2% | 15% | 19.2× | -6.8% | +6.9% |
| Allied Blenders and Distillers ABDL.NS | India | $2.39B | +50% | -20% | 11% | 71.6× | n/a | n/a |
| Boston Beer SAM | United States | $2.27B | +22% | -4% | 5% | 21.3× | 7.1% | +2.5% |
| Beijing Yanjing Brewery 000729.SZ | China | $4.90B | -6% | +7% | 16% | 16.1× | -3.8% | +7.3% |
| Anhui Yingjia Distillery 603198.SS | China | $5.15B | +23% | 0% | 41% | 16.5× | 4.8% | +11.7% |
| Sapporo Breweries 2501.T | Japan | $5.57B | +47% | -7% | 4% | 2.9× | 7.9% | +3.1% |
| Compania Cervecerias Unidas S.A. Sponsored ADR CCU | United States | $1.98B | -11% | +6% | 7% | 13.2× | 0.8% | +5.5% |
| Sichuan Swellfun 600779.SS | China | $1.91B | -16% | -30% | 20% | 42.8× | 15.3% | +0.1% |
| Jiangsu King's Luck Brewery Joint-stock 603369.SS | China | $6.08B | +18% | -5% | 33% | 15.3× | 1.0% | +15.3% |
| Radico Khaitan RADICO.NS | India | $6.69B | +30% | +16% | 17% | 68.7× | 46.1% | +20.5% |
| Hebei Hengshui Laobaigan Liquor 600559.SS | China | $1.54B | -15% | -17% | 11% | 28.9× | 13.1% | +2.4% |
| Anhui Kouzi Distillery 603589.SS | China | $1.54B | -22% | -19% | 13% | 21.2× | n/a | n/a |
| Jiugui Liquor 000799.SZ | China | $1.52B | -23% | +19% | -3% | 264.9× | n/a | n/a |
| Anhui Gujing Distillery 000596.SZ | China | $7.33B | +11% | -28% | 17% | 22.6× | 4.5% | +12.7% |